rs79790270

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001458.5(FLNC):​c.5669-12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0336 in 1,613,920 control chromosomes in the GnomAD database, including 1,150 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 93 hom., cov: 33)
Exomes 𝑓: 0.034 ( 1057 hom. )

Consequence

FLNC
NM_001458.5 intron

Scores

2
Splicing: ADA: 0.0003501
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.0410
Variant links:
Genes affected
FLNC (HGNC:3756): (filamin C) This gene encodes one of three related filamin genes, specifically gamma filamin. These filamin proteins crosslink actin filaments into orthogonal networks in cortical cytoplasm and participate in the anchoring of membrane proteins for the actin cytoskeleton. Three functional domains exist in filamin: an N-terminal filamentous actin-binding domain, a C-terminal self-association domain, and a membrane glycoprotein-binding domain. Mutations in this gene are a cause of cardiopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2022]
FLNC-AS1 (HGNC:53474): (FLNC antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 7-128851443-C-T is Benign according to our data. Variant chr7-128851443-C-T is described in ClinVar as [Benign]. Clinvar id is 258149.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-128851443-C-T is described in Lovd as [Benign]. Variant chr7-128851443-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0275 (4189/152324) while in subpopulation NFE AF= 0.0377 (2567/68028). AF 95% confidence interval is 0.0365. There are 93 homozygotes in gnomad4. There are 2170 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 4189 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLNCNM_001458.5 linkc.5669-12C>T intron_variant Intron 34 of 47 ENST00000325888.13 NP_001449.3 Q14315-1Q59H94
FLNCNM_001127487.2 linkc.5570-12C>T intron_variant Intron 33 of 46 NP_001120959.1 Q14315-2Q59H94
FLNC-AS1NR_149055.1 linkn.273G>A non_coding_transcript_exon_variant Exon 3 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLNCENST00000325888.13 linkc.5669-12C>T intron_variant Intron 34 of 47 1 NM_001458.5 ENSP00000327145.8 Q14315-1
FLNCENST00000346177.6 linkc.5570-12C>T intron_variant Intron 33 of 46 1 ENSP00000344002.6 Q14315-2
FLNC-AS1ENST00000469965.1 linkn.273G>A non_coding_transcript_exon_variant Exon 3 of 4 4

Frequencies

GnomAD3 genomes
AF:
0.0275
AC:
4190
AN:
152206
Hom.:
93
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00644
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0146
Gnomad ASJ
AF:
0.0207
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.0308
Gnomad FIN
AF:
0.0811
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0377
Gnomad OTH
AF:
0.0181
GnomAD3 exomes
AF:
0.0312
AC:
7794
AN:
249420
Hom.:
208
AF XY:
0.0318
AC XY:
4309
AN XY:
135356
show subpopulations
Gnomad AFR exome
AF:
0.00594
Gnomad AMR exome
AF:
0.0103
Gnomad ASJ exome
AF:
0.0204
Gnomad EAS exome
AF:
0.000111
Gnomad SAS exome
AF:
0.0303
Gnomad FIN exome
AF:
0.0765
Gnomad NFE exome
AF:
0.0388
Gnomad OTH exome
AF:
0.0278
GnomAD4 exome
AF:
0.0343
AC:
50078
AN:
1461596
Hom.:
1057
Cov.:
34
AF XY:
0.0346
AC XY:
25148
AN XY:
727108
show subpopulations
Gnomad4 AFR exome
AF:
0.00469
Gnomad4 AMR exome
AF:
0.0106
Gnomad4 ASJ exome
AF:
0.0192
Gnomad4 EAS exome
AF:
0.000176
Gnomad4 SAS exome
AF:
0.0311
Gnomad4 FIN exome
AF:
0.0710
Gnomad4 NFE exome
AF:
0.0367
Gnomad4 OTH exome
AF:
0.0269
GnomAD4 genome
AF:
0.0275
AC:
4189
AN:
152324
Hom.:
93
Cov.:
33
AF XY:
0.0291
AC XY:
2170
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.00642
Gnomad4 AMR
AF:
0.0146
Gnomad4 ASJ
AF:
0.0207
Gnomad4 EAS
AF:
0.000578
Gnomad4 SAS
AF:
0.0309
Gnomad4 FIN
AF:
0.0811
Gnomad4 NFE
AF:
0.0377
Gnomad4 OTH
AF:
0.0180
Alfa
AF:
0.0318
Hom.:
16
Bravo
AF:
0.0210
Asia WGS
AF:
0.0100
AC:
36
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Jan 13, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

5669-12C>T in intron 34 of FLNC: This variant is not expected to have clinical s ignificance because it has been identified in 3.5% (300/8532) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs79790270). -

Jul 29, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
6.4
DANN
Benign
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00035
dbscSNV1_RF
Benign
0.030
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs79790270; hg19: chr7-128491497; API